Trial Profile
Concentration-controlled Therapy of Mycophenolate Mofetil (MMF) in Proliferative Lupus Nephritis.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Mycophenolate mofetil (Primary)
- Indications Lupus nephritis
- Focus Therapeutic Use
- 20 Apr 2011 Planned end date changed from Jun 2010 to Dec 2011 as reported by ClinicalTrials.gov.
- 14 Jan 2010 New trial record